SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-019689
Filing Date
2023-01-31
Accepted
2023-01-31 07:28:54
Documents
14
Period of Report
2023-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d745957d8k.htm   iXBRL 8-K 26148
2 EX-99.1 d745957dex991.htm EX-99.1 34701
6 GRAPHIC g745957dsp1.jpg GRAPHIC 19908
  Complete submission text file 0001193125-23-019689.txt   219075

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sppi-20230131.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20230131_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20230131_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d745957d8k_htm.xml XML 3417
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 23570229
SIC: 2834 Pharmaceutical Preparations